Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Megestrol acetate for disordered proliferative or hyperplastic endometrium
IRCT201205265283N4Phase 2Completed
- Sponsor
- Women's Reproductive Health Research Center
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in endometrial hyperplasia (EH), disordered proliferative endometrium (DPE) and menstrual disorders comparing Metformin with Megestrol acetate (2 arms). Primary endpoint: Change in endometrial histology. Started Dec 2011; status: completed.
02
Drugs
metforminmegestrol
03
Conditions
endometrial hyperplasia (EH)disordered proliferative endometrium (DPE)menstrual disorders
Beyond the preview
Go deeper on IRCT201205265283N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201205265283N4.